BridgeBio Oncology Therapeutics Inc. Common Stock (BBOT)
BBOT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.95
-9.51% on the day
Market cap
$236.5M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | BBOT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001869105 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-09-01 |
| Latest annual report | 10-K | 2026-03-05 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-09-08 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 183 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| QTTB | Q32 Bio Inc. | $8.06 | -7.78% | $239.9M |
| IMRX | Immuneering Corporation | $3.56 | -7.77% | $230.3M |
| LFCR | Lifecore Biomedical Inc. | $6.42 | -0.31% | $243.0M |
| ACIU | AC Immune SA | $2.40 | -2.04% | $244.3M |
| AMRN | Amarin Corporation plc | $11.58 | +0.43% | $244.6M |
| IFRX | InflaRx N.V. | $1.55 | -2.52% | $228.4M |
| GLSI | Greenwich LifeSciences Inc. | $15.50 | -12.77% | $227.5M |
| ZNTL | Zentalis Pharmaceuticals Inc. | $2.40 | -4.76% | $227.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier